The reclassification would move marijuana away from its current classification as a Schedule I drug, alongside heroin and LSD ...

A recent study has found that two cannabis derivatives may aid in ovarian cancer treatment. The research indicates that CBD ...

Moving cannabis to a category of drugs that includes some common medicines will have implications for research, businesses ...

Cannabis industry observers believe it is increasingly likely that President Donald Trump will soon sign an executive order ...

The reclassifications of marijuana mark the biggest change to the federal legality of it since 1970. Here's what's happening.

President Donald Trump's executive order to reclassify marijuana has sparked optimism among Birmingham CBD store owners, who ...

A new systematic evidence review finds that cannabis products that carry relatively high levels of the psychoactive compound ...

Cannabis with more THC may slightly dull chronic pain—but the relief is modest, short-lived, and comes with trade-offs.

President Donald Trump will be signing an executive order on Thursday that will direct the attorney to “expedite” and “complete” the marijuana rescheduling process, throw a lifeline to the hemp ...

US President Trump's order placed emphasis on cannabidiol (CBD) and hemp-derived cannabinoid products. It called for ...

CBD products claiming therapeutic benefits are marketed not only for people but also for pets. Dr. Gene Pavlovsky, the ...

Researchers are exploring if cannabidiol can aid those wishing to reduce cannabis dependency, focusing on public health amid ...